Krka, d. d. (LJSE:KRKG)

Market Cap	6.35B
Revenue (ttm)	1.97B
Net Income (ttm)	380.92M
Shares Out	30.54M
EPS (ttm)	12.42
PE Ratio	16.74
Forward PE	16.42
Dividend	8.25 (4.04%)
Ex-Dividend Date	Jul 22, 2025

Volume	5,664
Average Volume	12,252
Open	206.00
Previous Close	208.00
Day's Range	202.00 - 206.00
52-Week Range	135.00 - 225.00
Beta	0.49
RSI	47.68
Earnings Date	Nov 13, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, oncology, pain relief, antiinfectives for systemic use, antidiabetics, and other products. It provides non-prescription prod...

• Industry: Pharmaceutical Preparations
• Founded: 1954
• Employees: 11,308
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: KRKG

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.